Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)

2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)

US Patent 9120830 · Granted Sep 1, 2015

Estimated economic value: $76,521,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Acylsulfonamide KAT6A inhibitors2025
Cyclopentaimidazolones for the treatment of cancer2024
Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors2022
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Indole derivatives as selective androgen receptor modulators (SARMS)2016
Quinuclidines for modulating alpha 7 activity2016
Cyclohexyl-azetidinyl antagonists of CCR22015
4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR22014
2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)2014
2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)2014
2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)2014
Indole derivatives as selective androgen receptor modulators (SARMS)2014